Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab) 2024-12-18 11:50
SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate 2024-12-12 21:00
ZEISS Debuts MYO 200 Biometer for Myopia Management in Hong Kong, Built on ZEISS "Gold Standard" Technology to Safeguard the Visual Health of Children and Adolescents 2024-12-03 15:13
HKBU scientist's Automated Multiplex Diagnostics System recommended by WHO as an innovative health technology for low-resource contexts 2024-12-03 15:03
Prenetics Announces Third Quarter 2024 Financial Results 2024-11-27 21:30
2024 Access to Medicine Index finds that pharma companies are missing opportunities to reach more patients in low- and middle-income countries 2024-11-19 21:00
WELLlife COVID-19/Influenza A&B Home Test on Sale for Black Friday and Cyber Monday 2024-11-18 21:00
Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Approved for 2 Clinical Trials by CDE of NMPA 2024-11-14 22:00
Join the GenScript Biotech Global Forum in London to Navigate the Future of Cell and Gene Therapies. 2024-11-13 23:51
PathogenDx Applauded by Frost & Sullivan for Enabling Early and Precise UTI Diagnosis with Its Microarray Detection Platform 2024-11-11 23:00
HKBN x INDICAID Introduce Hong Kong's First At-Home Health Test Monthly Subscription Service 2024-11-11 16:06
Mabwell Reveals Encouraging Pre-clinical Data of 7MW4811 at the 15th World ADC Conference 2024-11-08 22:00
ZYMFENTRA® (infliximab-dyyb) coverage continues to increase through partnership with top 3 Pharmacy Benefit Managers (PBMs) 2024-10-31 14:31
Celltrion presents post hoc analysis of LIBERTY studies of ZYMFENTRA®  (infliximab-dyyb) at the American College of Gastroenterology 2024 Annual Scientific Meeting 2024-10-30 03:25
LakeShore Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement 2024-10-29 20:30
DKSH and FrontierView Publish Whitepaper on Southeast Asia as a Growth Accelerator for Global Healthcare Firms 2024-10-28 09:00
LakeShore Biopharma Granted Phase III Clinical Trial Approval to Explore Simplified Regimens for YSJA Rabies Vaccine 2024-10-25 20:30
/C O R R E C T I O N -- Seegene Inc./ 2024-10-28 12:50
Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies 2024-10-16 17:43
Waters New Bioseparations Tools Accelerate and Improve Development of RNA-based Vaccines and Therapies Using LC-MS Analysis 2024-10-14 08:00